Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy

Leuk Lymphoma. 2021 Jul;62(7):1778-1781. doi: 10.1080/10428194.2021.1885654. Epub 2021 Feb 16.

¹ Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
² Department of Medicine, New York City Health + Hospitals, Bronx, NY, USA.
³ Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
⁵ Cancer Care Specialists of Illinois, Decatur, IL, USA.
⁶ Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

No abstract available

Publication types